Perioperative chemotherapy for gastric cancer: how should we measure the efficacy?

Roberto Persiani; Stefano Rausei; Alberto Biondi; Domenico D'Ugo

doi:10.1245/s10434-008-0310-7

Perioperative chemotherapy for gastric cancer: how should we measure the efficacy?

Research output: Contribution to journal › Article

3 Citations (Scopus)

Abstract

No abstract

Original language	English
Pages (from-to)	1077-1079
Number of pages	3
Journal	Annals of Surgical Oncology
Volume	16
DOIs	https://doi.org/10.1245/s10434-008-0310-7
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Antineoplastic Agents
Chemotherapy, Adjuvant
Humans
Neoadjuvant Therapy
Patient Selection
Perioperative Care
Stomach Neoplasms
Treatment Outcome

Access to Document

10.1245/s10434-008-0310-7

Cite this

@article{e44a019ab55c4205a0bf9ae90cedfbdc,

title = "Perioperative chemotherapy for gastric cancer: how should we measure the efficacy?",

abstract = "No abstract",

keywords = "Antineoplastic Agents, Chemotherapy, Adjuvant, Humans, Neoadjuvant Therapy, Patient Selection, Perioperative Care, Stomach Neoplasms, Treatment Outcome, Antineoplastic Agents, Chemotherapy, Adjuvant, Humans, Neoadjuvant Therapy, Patient Selection, Perioperative Care, Stomach Neoplasms, Treatment Outcome",

author = "Roberto Persiani and Stefano Rausei and Alberto Biondi and Domenico D'Ugo",

year = "2009",

doi = "10.1245/s10434-008-0310-7",

language = "English",

volume = "16",

pages = "1077--1079",

journal = "Annals of Surgical Oncology",